Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 85 displayed.
1 2 3 4 5 »

Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

Read more ››

By: GlobenewsWire - 26 Sep 2022

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 26 Sep 2022

Qu Biologics to Launch Phase 2B Clinical Trial to Assess Reduction of Postoperative Immune Suppression and Disease Progression in Patients with Late-Stage Colorectal Cancer

Read more ››

By: GlobenewsWire - 26 Sep 2022

More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec

Read more ››

By: GlobenewsWire - 22 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 19 Sep 2022

Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence

Read more ››

By: GlobenewsWire - 12 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 12 Sep 2022

SC Labs Names Cannabis Business Leader Hirsh Jain to its Board of Directors

Read more ››

By: GlobenewsWire - 07 Sep 2022

United Health Products Announces Equity Financing Agreement and Provides Corporate Update

Read more ››

By: GlobenewsWire - 06 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 05 Sep 2022

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Read more ››

By: GlobenewsWire - 01 Sep 2022

Lexogen Introduces RiboCop rRNA Depletion Kit for Yeast - a new library prep kit that enables efficient removal of rRNA and other transcripts

Read more ››

By: PR Newswire Association LLC. - 01 Sep 2022

Related companies: Lexogen GmbH

IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device

Read more ››

By: GlobenewsWire - 30 Aug 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 29 Aug 2022

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Read more ››

By: GlobenewsWire - 22 Aug 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 22 Aug 2022

EO Launches First-Ever Digital Health Platform Offering Affordable, Clinician-Guided Cannabis Care

Read more ››

By: GlobenewsWire - 17 Aug 2022

Novo Nordisk A/S: Share repurchase programme

Read more ››

By: GlobenewsWire - 15 Aug 2022

SC Labs Completes Rebrand of National Cannabis and Hemp Testing Network

Read more ››

By: GlobenewsWire - 15 Aug 2022

IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries

Read more ››

By: GlobenewsWire - 12 Aug 2022

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

September 2022
- BioPharm America™ 2022
October 2022
- Lisbon: Neuro, Digital & A.I. Innovation Summit
- BIO-Europe® 2022

Add an Event »

Latest company news

Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
26 Sep 2022 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
26 Sep 2022 (GlobenewsWire)

Qu Biologics to Launch Phase 2B Clinical Trial to Assess Reduction of Postoperative Immune Suppression and Disease Progression in Patients with Late-Stage Colorectal Cancer
26 Sep 2022 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com